Table 2 Prostate cancer risk by subgroups
Full cohort | Genotyped men | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NonPrCa* | PrCa | PrCa-risk | NonPrCa | PrCa | PrCa-risk | |||||||
Serum selenium(μg/l) | N | % | N | % | RR** | 95% CI*** | N | % | N | % | RR | 95% CI |
≤70 | 675 | (36.7) | 84 | (40.4) | Ref | - | 295 | (33.6) | 48 | (38.1) | Ref | - |
70.1-81.0 | 588 | (32.0) | 65 | (31.2) | 0.89 | (0.65 - 1.24) | 299 | (34.0) | 46 | (35.7) | 0.93 | (0.62 - 1.4) |
81+ | 574 | (31.2) | 59 | (28.4) | 0.83 | (0.60 - 1.16) | 285 | (32.4) | 33 | (26.2) | 0.72 | (0.46 - 1.12) |
Erythrocyte sedimentation rate, ESR(mm/h) | ||||||||||||
≤4.0 | 704 | (38.3) | 84 | (40.4) | Ref | - | 348 | (39.6) | 51 | (40.5) | Ref | - |
4.1-8.0 | 587 | (32.0) | 67 | (32.2) | 0.97 | (0.70 - 1.33) | 297 | (33.8) | 38 | (30.2) | 0.89 | (0.58 - 1.35) |
8+ | 545 | (29.7) | 57 | (27.4) | 0.88 | (0.63 - 1.23) | 234 | (26.6) | 37 | (29.4) | 1.07 | (0.7 - 1.62) |
Total serum cholesterol(mmol/l) | ||||||||||||
≤6.24 | 560 | (30.5) | 76 | (36.5) | Ref | - | 288 | (32.8) | 48 | (38.1) | Ref | - |
6.25-7.27 | 624 | (34.0) | 64 | (30.8) | 0.77 | (0.55 - 1.07) | 295 | (33.6) | 40 | (31.7) | 0.82 | (0.54 - 1.25) |
7.27+ | 653 | (35.5) | 68 | (32.7) | 0.78 | (0.56 - 1.08) | 296 | (33.7) | 38 | (30.2) | 0.78 | (0.51- 1.19) |
BMI(kg/m 2 ) | ||||||||||||
≤23.4 | 605 | (32.9) | 61 | (29.3) | Ref | - | 296 | (33.7) | 39 | (31.0) | Ref | - |
23.5-26.0 | 567 | (30.9) | 78 | (37.5) | 1.34 | (0.96 - 1.87) | 285 | (32.4) | 50 | (39.7) | 1.31 | (0.86 - 1.99) |
26+ | 665 | (36.2) | 69 | (33.2) | 1.03 | (0.73 - 1.46) | 298 | (33.9) | 37 | (29.4) | 0.96 | (0.61 - 1.5) |
Smoking | ||||||||||||
non-smoker | 449 | (24.4) | 69 | (33.2) | Ref | - | 258 | (29.4) | 45 | (35.7) | Ref | - |
smoker | 961 | (52.3) | 86 | (41.3) | 0.6 | (0.44 - 0.83) | 394 | (44.8) | 47 | (37.3) | 0.70 | (0.46 - 1.05) |
ex-smoker | 427 | (23.2) | 53 | (25.5) | 0.82 | (0.58 - 1.18) | 227 | (25.8) | 34 | (27.0) | 0.87 | (0.56 - 1.36) |